TUNCEL, M. Et Al. 2015. Clinical impact of Ga-68-DOTATATE in patients with neuroendrocrine tumors. 3rd Theranostics World Congress on Gallium-68 and PRRT , (Maryland, United States Of America).

TUNCEL, M., KILIÇKAP, S., & Akdemir, E., (2015). Clinical impact of Ga-68-DOTATATE in patients with neuroendrocrine tumors . 3rd Theranostics World Congress on Gallium-68 and PRRT, Maryland, United States Of America

TUNCEL, MURAT, SAADETTİN KILIÇKAP, And E. Akdemir. "Clinical impact of Ga-68-DOTATATE in patients with neuroendrocrine tumors," 3rd Theranostics World Congress on Gallium-68 and PRRT, Maryland, United States Of America, 2015

TUNCEL, MURAT Et Al. "Clinical impact of Ga-68-DOTATATE in patients with neuroendrocrine tumors." 3rd Theranostics World Congress on Gallium-68 and PRRT , Maryland, United States Of America, 2015

TUNCEL, M. KILIÇKAP, S. And Akdemir, E. (2015) . "Clinical impact of Ga-68-DOTATATE in patients with neuroendrocrine tumors." 3rd Theranostics World Congress on Gallium-68 and PRRT , Maryland, United States Of America.

@conferencepaper{conferencepaper, author={MURAT TUNCEL Et Al. }, title={Clinical impact of Ga-68-DOTATATE in patients with neuroendrocrine tumors}, congress name={3rd Theranostics World Congress on Gallium-68 and PRRT}, city={Maryland}, country={United States Of America}, year={2015}}